Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amgen VP-Licensing Scott Foraker: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)

Nov 20 2006

• By Jonathan M. Block

Related Content

Amgen To Acquire Panitumumab Development Partner Abgenix

Dec 14 2005

Amgen Will Develop Predix S1P1 Modulators For Autoimmune Diseases

Aug 01 2006

Amgen VP-Licensing Scott Foraker: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)

Nov 17 2006

Amgen's $1.3 Bil. Acquisition Of Tularik Would Yield Two Late-Stage Oncologics

Mar 29 2004

Amgen Expands Inflammation Pipeline With Avidia Purchase

Sep 29 2006

Amgen Licenses Erbitux-Related Patent After ImClone Court Loss

Sep 19 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window